Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
Explore this paper's citation graph
Summary
It is suggested that specific miRs are downregulated in a pre-clinical model of PD and hold the potential to be used as biomarkers to aid in the diagnosis of this disease.
- Type
- article
- Published
- 2018-11-01
- Cited by
- 20
- References
- 43
- Access
- Open access
- OpenAlex
- https://openalex.org/W30025832
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:51702128
Keywords
Computer science
References
- A guide to miRNAs in inflammation and innate immune responses
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
- Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment.
- Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's disease
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
- Clinical Progression in Parkinson's Disease and the Neurobiology of Axons
- MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines
- Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
- Deletion of the parkin and PACRG gene promoter in early‐onset parkinsonism
- Biomarkers of Parkinson's disease: Present and future
- The spectrum of nonmotor symptoms in early Parkinson disease
- Blood-Based Biomarkers for Parkinson’s Disease
- Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
- Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.
- Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
- Parkinson’s disease: animal models and dopaminergic cell vulnerability
- MiR‐124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
- An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
Cited by
- MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
- Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
- miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
- Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
- Role of MicroRNAs in Parkinson’s Disease
- Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker
- Modulation of NMDA receptor by miR-219 in the amygdala and hippocampus of patients with mesial temporal lobe epilepsy.
- A new sensor for detecting microrna 133B (Parkinson’s disease biomarker)
- Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration
- A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson’s patients is associated with the early stage onset of disease
- Evolutionary Changes in the Interaction of miRNA With mRNA of Candidate Genes for Parkinson’s Disease
- miR-124: A Promising Therapeutic Target for Central Nervous System Injuries and Diseases
- MitomiRs: Their Roles in Mitochondria and Importance in Cancer Cell Metabolism
- miRNA in Parkinson's disease: From pathogenesis to theranostic approaches
- Meta-analysis of Circulatory mitomiRs in stress Response: Unveiling the significance of miR-34a and miR-146a.
- Role of microRNAs in tumor progression by regulation of kinesin motor proteins.
- Suppression of endometriosis by miRNA-34a via inhibition of matrix metalloproteinase-2: An alternative pathway to impede invasion
- Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols
- Green-Synthesized Silver Nanoparticles with Nigella sativa: A Multifaceted Approach against Parkinson's Disease in Rats via MicroRNA Modulation.
- Oxytocin promotes invasiveness in endometriotic cells via miR-34a and miR-145: Influence of matrix metalloprotease-2
Related papers
No related papers recorded.